WHO ICTRP trial
OMS721 in patients with IgA Nephropathy (ARTEMIS-IGAN)
EUCTR2018-000075-33-CZ · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2018-000075-33-CZ |
|---|---|
| Public title | OMS721 in patients with IgA Nephropathy (ARTEMIS-IGAN) |
| Scientific title | A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Safety and Efficacy of OMS721 in Patients with Immunoglobulin A (IgA) Nephropathy (ARTEMIS – IGAN) - ARTEMIS-IGAN |
| Primary sponsor | Omeros Corporation |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no |
| Countries | Singapore;Hungary;United States;Philippines;United Kingdom;Malaysia;Thailand;Spain;Greece;Canada;Czech Republic;Sweden;Austria;Belgium;Taiwan;Korea, Republic… |
| Conditions | IgA nephropathy (IgAN) MedDRA version: 20.1 Level: PT Classification code 10029151 Term: Nephropathy System Organ Class: 10038359 - Renal and urinary disorders ;Therapeutic area: Diseases [C] - Immune System Diseases [C20] |
| Interventions | Product Code: OMS721 Pharmaceutical Form: Solution for infusion INN or Proposed INN: OMS721 Other descriptive name: OMS721 Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 370- Pharmaceutical form of the… |
| Registration date | Jun 4, 2018 |
| Target size | 450 |
| Secondary IDs | OMS721-IGA-001;2018-000075-33-HU |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: